A similar mechanism was observed in FLT3-ITD-negative AML cells, where ibrutinib suppressed NF-κB and STAT5-mediated transcription downstream of the TLR9/BTK transducer module [35]. The gene discussed is NFKB1; the disease is acute myeloid leukemia.